[go: up one dir, main page]

Latest News for: glp 1

Edit

Rising GLP-1 Use Linked to Protein, Fiber and Vitamin Deficiencies, Study Shows

Princeton Daily Clarion 26 Feb 2026
households reports using a GLP-1 medication, and ...
Edit

Considering MEDVi Tirzepatide GLP-1 Weight Loss in 2026? Read This Before Enrolling in Any Tirzepatide ...

Nasdaq Globe Newswire 26 Feb 2026
Informational overview of MEDVi's compounded tirzepatide GLP-1 telehealth weight loss program, regulatory classification, and pricing disclosures ... .
Edit

Sprout Health GLP-1 Weight Loss in 2026 — Compounded Semaglutide Pricing, FDA Status, and What ...

Nasdaq Globe Newswire 26 Feb 2026
Informational overview of Sprout Health's compounded GLP-1 telehealth model, semaglutide and tirzepatide pricing, and FDA status for 2026 ... .
Edit

MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001

Nasdaq Globe Newswire 26 Feb 2026
MindRank, artificial intelligence (AI)-empowered drug discovery company, announced FPI in Phase III Trial of an Oral GLP-1 Receptor Agonist MDR-001 ... .
Edit

True Rx Health Strategists Collaborates with Waltz Health to Provide Direct-to-Employer, Industry-Leading GLP-1 Pricing

Guymon Daily Herald 26 Feb 2026
New direct model delivers an in-network pathway for GLP-1 access ... .
Edit

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita� for Post-GLP-1 Weight Maintenance

Nasdaq Globe Newswire 26 Feb 2026
Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application submission expected in late Q4 2026 ... .
Edit

Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Results of Phase III ACHIEVE-3 Trial for Type 2 Diabetes) (Chugai Pharmaceutical Co Ltd)

Public Technologies 26 Feb 2026
Eli Lilly's Announcement Regarding Oral GLP-1 Orforglipron (Results of Phase III ACHIEVE-3 Trial for Type 2 Diabetes) ... Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and ...
Edit

Tanmay Bhat Opens Up About GLP-1 Drugs Not Working And His Genetic Report

News18 26 Feb 2026
Tanmay Bhat says GLP-1 weight-loss drugs did not suppress his appetite and revealed a genetic variant that may affect satiety signalling ....
Edit

New daily weight loss pill surpasses existing oral GLP-1 medication in trial - could become ...

The Daily Mail 26 Feb 2026
A new pill could help patients lose more weight and gain better control of their blood sugar levels than current weight loss medications, a promising new study has found ....
Edit

New GLP-1 pill helps patients lose up to 8% of body weight, trial shows

The Guardian 26 Feb 2026
A new daily pill could be a more effective GLP-1 tablet for weight loss, according to a clinical trial that may pave the way for ...
Edit

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance (Form 8-K) (Fractyl Health Inc)

Public Technologies 26 Feb 2026
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance ... Following GLP-1 discontinuation, participants were randomized 2.1 to receive Revita or a sham endoscopic procedure.
Edit

Will GLP-1 pills change diabetes treatment?

Observer-Reporter 26 Feb 2026
Food and Drug Administration (FDA) recently approving GLP-1 drug Wegovy in pill form for use in weight loss and fighting obesity, the question arises whether other GLP-1 drugs will also soon become available in a pill rather than a needle.
Edit

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

PR Newswire 26 Feb 2026
"ACHIEVE-3 gives us the first head-to-head comparison between two oral GLP-1 receptor agonist therapies in adults with type 2 diabetes, and the differences were clinically meaningful," said Dr.
Edit

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People ...

Business Insider 26 Feb 2026
People with diabetes lost an average of nearly 20 pounds of body weight during a clinical trial of orforglipron, which is a new small molecule GLP-1 drug ... Eli Lilly has been building out its manufacturing capacity, racing to meet demand for GLP-1s.
Edit

Ivim Health GLP-1 Weight Loss Program: Individualized Dosing, Pricing, and What Consumers Should Know in 2026

Nasdaq Globe Newswire 25 Feb 2026
Ivim Health GLP-1 weight loss program offers compounded semaglutide and tirzepatide with weekly provider check-ins and individualized dosing ... .

Article Search

tools
×
×
×
×